Ashiya, Japan

Hiroshi Muta

This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Muta. Retrieved from https://idiyas.com/inventor/hiroshi-muta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroshi Muta: Innovator in Pharmaceutical Research

Introduction

Hiroshi Muta is a notable inventor based in Ashiya, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic potential. His work is characterized by a focus on innovative solutions to complex medical challenges.

Latest Patents

Hiroshi Muta holds a patent for "Carbostyril derivatives for inhibiting production of interleukin-8." This invention is crucial in the context of inflammatory diseases, as interleukin-8 plays a significant role in the inflammatory response. His patent portfolio includes 1 patent, showcasing his commitment to advancing medical science.

Career Highlights

Muta is currently employed at Otsuka Pharmaceutical Company, Limited, where he continues to engage in groundbreaking research. His role at Otsuka allows him to collaborate with other experts in the field and contribute to the development of innovative pharmaceutical products.

Collaborations

Throughout his career, Hiroshi Muta has worked alongside talented colleagues, including Takahide Matsuda and Miki Aihara. These collaborations have fostered a creative environment that encourages the exchange of ideas and the pursuit of innovative solutions.

Conclusion

Hiroshi Muta's contributions to pharmaceutical research exemplify the impact of innovation in medicine. His work not only advances scientific knowledge but also holds the potential to improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…